It is a pharma public limited company based in New Delhi, Delhi, India, established in 1994.
1994 | New Delhi, Delhi, India | ActiveGrowel Remedies Limited, a active public limited company, was established on 12 August 1994 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397DL1994PLC060862. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.46 M.
Formerly known as Growel International Private Limited, Growel Biotech Private Limited. It upholds a compliant status. Its leadership includes Tejasvi Bishnoi (Director), Rahul Bishnoi (Director), Ashwani Kumar Sharma (Director). Past directors included Harish Pande. It holds ₹5.00 Cr open charges and ₹7.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1506 Chiranjiv Tower 43 Nehru Place, New Delhi, Delhi, 110019.
U51397DL1994PLC060862
060862
12 August 1994
₹2.50 M
₹2.46 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Growel Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejasvi Bishnoi | Director | 12 Aug 1994 | Current |
| Rahul Bishnoi | Director | 15 Oct 1994 | Current |
| Ashwani Kumar Sharma | Director | 14 Nov 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Oct 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Growel Remedies Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.52% decrease. The company also saw a slight decrease in profitability, with a 4.54% decrease in profit. The company's net worth Soared by an impressive increase of 52.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Growel Remedies had a promoter holding of 75.50% and a public holding of 24.50%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹70,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2019 | Others | ₹5.00 Cr | Open |
| 24 Jul 2018 | Others | ₹7.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Growel Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Growel Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Growel Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Growel Remedies Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Growel Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on A charge registered on 24 Jul 2018 via Charge ID 100199550 with Others was fully satisfied on 07 Jul 2023. was documented.
A charge with Others of Rs. 70.00 M registered on 24 Jul 2018 with Charge ID 100199550 was modified on 28 Sep 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 50.00 M with Charge ID 100245010 was registered on 21 Feb 2019. was completed.
A charge with Others amounted to Rs. 70.00 M with Charge ID 100199550 was registered on 24 Jul 2018. was recorded as a recent event.
The CIN of Growel Remedies Limited is U51397DL1994PLC060862.
Growel Remedies Limited is headquartered at 1506 Chiranjiv Tower 43 Nehru Place, New Delhi, Delhi, 110019.
Growel Remedies Limited was incorporated on 12 August 1994.
The current directors of Growel Remedies Limited are
The primary industry of Growel Remedies Limited is Trade.
Growel Remedies Limited is unlisted.
The authorized capital of Growel Remedies Limited is ₹2.50 M, and the paid-up capital is ₹2.46 M.
The compliance status of Growel Remedies Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX